Living-Donor Liver Transplant Follow-Up: A Single Center Experience

被引:1
|
作者
Laeeq, Syed Mudassir [1 ]
Hanif, Farina M. [1 ]
Luck, Nasir Hassan [1 ]
Mandhwani, Rajesh Kumar [1 ]
Iqbal, Jawed [1 ]
Mehdi, Syed Haider [2 ]
机构
[1] Sindh Inst Urol & Transplantat, Dept Hepatogastroenterol, Karachi 74200, Pakistan
[2] Sindh Inst Urol & Transplantat, Dept Hepatobiliary Surg, Karachi, Pakistan
关键词
Anti-viral agents; Diabetes mellitus; Dyslipidemia; HCV; Hypertension; HEPATITIS-C VIRUS; RISK-FACTORS; HCV; SOFOSBUVIR; INFECTION; RIBAVIRIN;
D O I
10.6002/ect.mesot2016.P122
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: Liver transplant is a definite treatment of decompensated liver disease. Because of the shortage of livers from deceased donors, living-donor liver transplant is becoming more common. Here, we analyzed our clinical experience in the follow-up care of these patients. Materials and Methods: Liver transplant recipients seen at the Sindh Institute of Urology and Transplantation (Karachi, Pakistan) were included in this analysis. Baseline characteristics and follow-up events were recorded. Results: Our study population included 76 liver transplant patients registered at our clinic. Median age was 42 years, with 62 patients (81.6%) being males. The most common indication of transplant was hepatitis C virus-related cirrhosis (42 patients; 55%), followed by hepatitis B-hepatitis D virus coinfection (8 patients; 10.5%). Anastomotic biliary stricture developed in 16 patients (21.1%), which required biliary stenting. Biliary leak developed in 5 patients (6.6%), and renal cell carcinoma developed in 1 patient. Two recipients died due to hepatitis C virus-related fibrosing cholestasis hepatitis and pulmonary complications. Posttransplant diabetes mellitus developed in 36 (47.1%), hypertension in 17 (38.6%), and dyslipidemia in 19 patients (25%). Of 42 patients with hepatitis C virus infection, 26 were treated with pegylated interferon and ribavirin, of which 65.3% achieved sustained virologic response at 24 weeks. The other 16 patients received sofosbuvir combined with ribavirin for 24 weeks. A sustained virologic response at 12 weeks was achieved in 5 patients, with not yet determined results in the remaining patients. Seven patients were lost to follow-up. Conclusions: Hepatitis C-related cirrhosis was the most common indication for liver transplant, and infection recurrence was observed in our patients. Biliary anastomotic stricture formation was the most prevalent complication after transplant. As liver transplants are becoming more widely available for Pakistani patients at home and abroad, gastroenterologists and trainees in our country should be sensitized, educated, and skilled in the posttransplant care of these patients.
引用
收藏
页码:254 / 257
页数:4
相关论文
共 50 条
  • [21] Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up
    Lee, Yu-Ji
    Kim, Beom
    Lee, Jung Eun
    Kim, Yoon-Goo
    Kim, Dae Joong
    Kim, Sung-Joo
    Joh, Jae-Won
    Oh, Ha Young
    Huh, Wooseong
    TRANSPLANT INTERNATIONAL, 2010, 23 (02) : 147 - 154
  • [22] Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases
    Iida, T.
    Kaido, T.
    Yagi, S.
    Hori, T.
    Uchida, Y.
    Jobara, K.
    Tanaka, H.
    Sakamoto, S.
    Kasahara, M.
    Ogawa, K.
    Ogura, Y.
    Mori, A.
    Uemoto, S.
    CLINICAL TRANSPLANTATION, 2014, 28 (09) : 1025 - 1030
  • [23] Risk factors for BK virus infection in living-donor renal transplant recipients: a single-center study from China
    Li, Ping
    Cheng, Dongrui
    Wen, Jiqiu
    Xie, Kenan
    Li, Xue
    Ni, Xuefeng
    Ji, Shuming
    Chen, Jinsong
    RENAL FAILURE, 2018, 40 (01) : 442 - 446
  • [24] Delayed graft function in living-donor renal transplantation: a single-center experience with 1537 patients
    Ozkul, Faruk
    Erbis, Halil
    Yilmaz, Vural Taner
    Ozturk, Bunyamin
    Kocak, Huseyin
    Osmanoglu, Ibrahim Ali
    Dinckan, Ayhan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 6716 - 6719
  • [25] Surgical site infection in living-donor liver transplant recipients: A prospective study
    Iinuma, Y
    Senda, K
    Fujihara, N
    Saito, T
    Takakura, S
    Kudo, T
    Kiuchi, T
    Tanaka, K
    Ichiyama, S
    TRANSPLANTATION, 2004, 78 (05) : 704 - 709
  • [26] Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt
    Saleh, Ahmed Mohamed
    Hassan, Essam Ali
    Gomaa, Ahmed Ali
    El Baz, Tamer Mahmoud
    El-Abgeegy, Mohamed
    Seleem, Mohamed Ismail
    Abo-amer, Yousry Esam-Eldin
    Elsergany, Heba Fadl
    Mahmoud, Eman Ibrahim El-Desoki
    Abd-Elsalam, Sherief
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 2277 - 2282
  • [27] Clinical features and risk factors of tuberculosis in living-donor liver transplant recipients
    Imai, S.
    Ito, Y.
    Hirai, T.
    Imai, H.
    Ito, I.
    Maekawa, K.
    Chin, K.
    Ichiyama, S.
    Uemoto, S.
    Mishima, M.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (01) : 9 - 16
  • [28] Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center
    Wahab, M. A.
    Shehta, A.
    Elshoubary, M.
    Yassen, A. M.
    Elmorshedi, M.
    Salah, T.
    Sultan, A. M.
    Fathy, O.
    Elsarraf, W. R.
    Shiha, U.
    Zalata, K.
    Elghawalby, A. N.
    Eldesoky, M.
    Monier, A.
    Said, R.
    Elsabagh, A. M.
    Ali, M.
    Kandeel, A.
    Abdalla, U.
    Aboelella, M.
    Elsadany, M.
    Abdel-Khalek, E. E.
    Marwan, A.
    ElMorsi, F. M.
    Adly, R.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1396 - 1406
  • [29] Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center
    Gossmann, J
    Wilhelm, A
    Kachel, HG
    Jordan, J
    Sann, U
    Geiger, H
    Kramer, W
    Scheuermann, EH
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2417 - 2424
  • [30] Central Pontine Myelinolysis After Living-Donor Liver Transplant: A Report of 2 Cases
    Hsu, Ya-Lan
    Hsieh, Chia-En
    Lin, Kuo-Hua
    Chou, Chen-Te
    Lin, Ping-Yi
    Wang, Su-Han
    Chen, Yao-Li
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 (04) : 564 - 567